Cervical cancer secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
The [[HPV test]] is a newer technique for cervical cancer screening which detects the presence of [[human papillomavirus]] infection in the cervix. It is more [[sensitivity (tests)|sensitive]] than the pap smear (less likely to produce false negative results), but less specific (more likely to produce false positive results) and its role in routine screening is still evolving. Since more than 99% of invasive cervical cancers worldwide contain HPV, some researchers recommend that HPV testing be done together with routine cervical screening (Walboomers ''et al'', 1999). But, given the prevalence of HPV (around 80% infection history among the sexually active population) others suggest that routine HPV testing would cause undue alarm to carriers. | The [[HPV test]] is a newer technique for cervical cancer screening which detects the presence of [[human papillomavirus]] infection in the cervix. It is more [[sensitivity (tests)|sensitive]] than the pap smear (less likely to produce false negative results), but less specific (more likely to produce false positive results) and its role in routine screening is still evolving. Since more than 99% of invasive cervical cancers worldwide contain HPV, some researchers recommend that HPV testing be done together with routine cervical screening (Walboomers ''et al'', 1999). But, given the prevalence of HPV (around 80% infection history among the sexually active population) others suggest that routine HPV testing would cause undue alarm to carriers. | ||
see also [[cervical cancer screening]] | *see also [[cervical cancer screening]] | ||
see also [[pap test]] | *see also [[pap test]] | ||
see also [[HPV test]] | *see also [[HPV test]] | ||
see also [[colposcopy]] | *see also [[colposcopy]] | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 13:10, 25 August 2015
|
Cervical cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cervical cancer secondary prevention On the Web |
|
American Roentgen Ray Society Images of Cervical cancer secondary prevention |
|
Risk calculators and risk factors for Cervical cancer secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [3]
Screening
The widespread introduction of the Papanicolaou test, or pap smear for cervical cancer screening has been credited with dramatically reducing the incidence and mortality of cervical cancer in developed countries.[1] The pap smear suggests the presence of cervical intraepithelial neoplasia (premalignant changes in the cervix) before a cancer has developed, allowing for further workup. Recommendations for how often a Pap smear should be done vary from once a year to once every five years. The American Cancer Society recommends that cervical cancer screening should begin approximately three years after the onset of vaginal intercourse and/or no later than twenty-one years of age.[2] If premalignant disease or cervical cancer is detected early, it can be treated relatively noninvasively, and without impairing fertility.
The HPV test is a newer technique for cervical cancer screening which detects the presence of human papillomavirus infection in the cervix. It is more sensitive than the pap smear (less likely to produce false negative results), but less specific (more likely to produce false positive results) and its role in routine screening is still evolving. Since more than 99% of invasive cervical cancers worldwide contain HPV, some researchers recommend that HPV testing be done together with routine cervical screening (Walboomers et al, 1999). But, given the prevalence of HPV (around 80% infection history among the sexually active population) others suggest that routine HPV testing would cause undue alarm to carriers.
- see also cervical cancer screening
- see also pap test
- see also HPV test
- see also colposcopy